Peng Lei

Mr. Peng Lei

Tianjin University of Traditional Chinese Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MHMingshuai He
Mingshuai He
HYHeshui Yu
Heshui Yu
PLPeng Lei
Peng Lei
Shengjie HuangShengjie Huang
Shengjie Huang
娟任娟宁 任
娟宁 任
MJMiaomiao Jiang
Miaomiao Jiang
Trimethylamine N-oxide (TMAO), as a gut-derived metabolite, has been found to be associated with enhanced risk for atherosclerosis and cardiovascular disease. We presented a method for targeted profiling of TMAO and betaine in serum and food samples based on a combination of one-step sample pretreatment and proton nuclear magnetic resonance spectroscopy. The key step included a processing of sample preparation using a selective solid-phase extraction column for retention of basic metabolites. Proton signals at δ 3.29 and δ 3.28 were employed to quantify TMAO and betaine, respectively. The developed method was examined with acceptable linear relationship, precision, stability, repeatability, and accuracy. It was successfully applied to detect serum levels of TMAO and betaine in TMAO-fed mice and high-fructose-fed rats and also used to determine the contents of TMAO and betaine in several kinds of food, such as fish, pork, milk, and egg yolk.

17 July 2025 in Eurasian Journal of Medicine and Oncology
Verified
Journal Article
Open access
PDF file
JDJianbing Dong
Jianbing Dong
ZZZhirong Zhou
Zhirong Zhou
YCYi Chen
Yi Chen
PLPeng Lei
Peng Lei
QZQingrui Zhang
Qingrui Zhang
MJMiaomiao Jiang
Miaomiao Jiang
Introduction: Dan-Shen-Yin (DSY), a traditional Chinese medicinal prescription composed of Salvia miltiorrhiza Bge. (DS), Santalum album L. (TX) and Amomum villosum Lour. (SR), has been widely employed in the treatment of gastritis in modern clinical practice and demonstrates excellent therapeutic efficacy. However, the main active ingredient and underlying mechanisms of action remain unclear. Objective: The aim of this study is to comprehensively characterize the chemical composition of DSY and elucidate its potential mechanisms in the treatment of gastritis. Methods: The nonvolatile compounds in DSY were analyzed through liquid chromatography-mass spectrometry using the data-dependent acquisition approach, employing an in-house database. The volatile compounds and polysaccharides were detected by gas chromatography-mass spectrometry and high-performance liquid chromatography, respectively. Network pharmacology analysis was performed based on the identified compounds. Results: A total of 52 nonvolatile and 15 volatile compounds were identified in DSY decoction, primarily including phenylpropanoids, phenols, flavonoids, and terpenoids. Specifically, 54 compounds were found in DS, 14 in SR, and 8 in TX. DSY polysaccharide consisted of seven kinds of monosaccharides, including mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose, with molar percentages of 0.21%, 0.53%, 0.15%, 4.12%, 6.24%, 18.07%, and 0.84%, respectively. Network pharmacology analysis identified 22 key compounds among the 67 compounds detected. These compounds exert the therapeutic effects through 55 core targets (e.g., interleukin-6, tumor necrosis factor, and TP53) and 10 inflammation-related pathways, such as the MAPK and nuclear factor kappa B signaling pathways. Conclusion: This study further enriches the research on the material basis of DSY and reveals that its volatile compounds, nonvolatile compounds, and polysaccharides contribute to its therapeutic efficacy against gastritis. These findings may facilitate further development and application of DSY in gastritis treatment.